Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -796 | -1,379 | -1,477 | -1,652 | -2,083 |
| Depreciation Amortization | 62 | 177 | 290 | 268 | 369 |
| Accounts receivable | -19 | -147 | 38 | -42 | 18 |
| Accounts payable and accrued liabilities | 159 | -48 | -109 | 0 | 29 |
| Other Working Capital | 181 | 1 | -64 | 148 | 194 |
| Other Operating Activity | 408 | 1,136 | 794 | 783 | 306 |
| Operating Cash Flow | $-6 | $-260 | $-527 | $-497 | $-1,168 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -53 | -64 | -183 | -58 | -228 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -66 |
| Other Investing Activity | 3 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-50 | $-64 | $-183 | $-58 | $-294 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 38 | 193 | N/A | 248 | N/A |
| Common Stock Issued | N/A | N/A | 843 | N/A | N/A |
| Other Financing Activity | 2 | 7 | 21 | -515 | -85 |
| Financing Cash Flow | $40 | $200 | $864 | $-267 | $-85 |
| Exchange Rate Effect | -1 | 4 | -4 | -3 | 3 |
| Beginning Cash Position | 78 | 206 | 57 | 348 | 1,892 |
| End Cash Position | 61 | 87 | 206 | 57 | 348 |
| Net Cash Flow | $-17 | $-120 | $149 | $-291 | $-1,544 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6 | -260 | -527 | -497 | -1,168 |
| Capital Expenditure | -53 | -64 | -183 | -58 | -228 |
| Free Cash Flow | -59 | -324 | -711 | -554 | -1,396 |